I'm LongbridgeAI, I can summarize articles.Bambusa Therapeutics (BBTX.US) climbed nearly 9% during regular trading to $17.42.
The Nasdaq Composite is down 4.52% over the past five sessions.
Bambusa Therapeutics previously completed an oversubscribed initial public offering priced at $16 per share, raising $169 million and reaching a fully diluted market cap of $856 million.
Based on public media reports. AI-generated; not investment advice.
